Difference between revisions of "Glypican 3"

Jump to navigation Jump to search
272 bytes added ,  00:51, 30 September 2015
(create)
 
Line 3: Line 3:
==Positive==
==Positive==
*[[Hepatocellular carcinoma]].<ref name=pmid25896897>{{Cite journal  | last1 = Aydin | first1 = O. | last2 = Yildiz | first2 = L. | last3 = Baris | first3 = S. | last4 = Dundar | first4 = C. | last5 = Karagoz | first5 = F. | title = Expression of Glypican 3 in low and high grade urothelial carcinomas. | journal = Diagn Pathol | volume = 10 | issue =  | pages = 34 | month =  | year = 2015 | doi = 10.1186/s13000-015-0266-4 | PMID = 25896897 }}</ref>
*[[Hepatocellular carcinoma]].<ref name=pmid25896897>{{Cite journal  | last1 = Aydin | first1 = O. | last2 = Yildiz | first2 = L. | last3 = Baris | first3 = S. | last4 = Dundar | first4 = C. | last5 = Karagoz | first5 = F. | title = Expression of Glypican 3 in low and high grade urothelial carcinomas. | journal = Diagn Pathol | volume = 10 | issue =  | pages = 34 | month =  | year = 2015 | doi = 10.1186/s13000-015-0266-4 | PMID = 25896897 }}</ref>
*[[Malignant melanoma]].<ref name=pmid25896897/>
*[[Squamous cell carcinoma of the lung]].<ref name=pmid25896897/>
*[[Yolk sac tumour]].
===Images===
*[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414302/figure/Fig1/ Glypican 3 in UCC (nih.gov)].<ref name=pmid25896897/>


==See also==
==See also==
48,536

edits

Navigation menu